Literature DB >> 9847182

IMGT, the international ImMunoGeneTics database.

M P Lefranc1, V Giudicelli, C Ginestoux, J Bodmer, W Müller, R Bontrop, M Lemaitre, A Malik, V Barbié, D Chaume.   

Abstract

IMGT, the international ImMunoGeneTics database (http://imgt.cnusc. fr:8104), is a high-quality integrated database specialising in Immunoglobulins (Ig), T cell Receptors (TcR) and Major Histocompatibility Complex (MHC) molecules of all vertebrate species, created in 1989 by Marie-Paule Lefranc, Université Montpellier II, CNRS, Montpellier, France (lefranc@ligm.igh.cnrs.fr). IMGT comprises three databases: LIGM-DB, a comprehensive database of Ig and TcR, MHC/HLA-DB, and PRIMER-DB (the last two in development); a tool, IMGT/DNAPLOT, developed for sequence analysis and alignments; and expertised data based on the IMGT scientific chart, the IMGT repertoire. By its high quality and its easy data distribution, IMGT has important implications in medical research (repertoire in autoimmune diseases, AIDS, leukemias, lymphomas), therapeutic approaches (antibody engineering), genome diversity and genome evolution studies. IMGT is freely available at http://imgt.cnusc. fr:8104

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847182      PMCID: PMC148137          DOI: 10.1093/nar/27.1.209

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  145 in total

1.  FIMM, a database of functional molecular immunology.

Authors:  C Schönbach; J L Koh; X Sheng; L Wong; V Brusic
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  IMGT, the international ImMunoGeneTics database.

Authors:  M P Lefranc
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

3.  Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F.

Authors:  Jianhui Zhou; Kathleen R Lottenbach; Stephen J Barenkamp; Alexander H Lucas; Donald C Reason
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.

Authors:  Zheng Pu; Javier A Carrero; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

5.  The KNOTTIN website and database: a new information system dedicated to the knottin scaffold.

Authors:  Jean-Christophe Gelly; Jérôme Gracy; Quentin Kaas; Dung Le-Nguyen; Annie Heitz; Laurent Chiche
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

6.  IMGT, the international ImMunoGeneTics database.

Authors:  Marie-Paule Lefranc
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

7.  Patterns of gene divergence and VL promoter activity in immunoglobulin light chain clusters of the channel catfish.

Authors:  Julia Cay Jones; Seyed H Ghaffari; Craig J Lobb
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

8.  Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.

Authors:  Esther Dawen Yu; Enrico Girardi; Jing Wang; Thien-Thi Mac; Karl O A Yu; Serge Van Calenbergh; Steven A Porcelli; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

9.  Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.

Authors:  Paola Martinez-Murillo; Karen Tran; Javier Guenaga; Gustaf Lindgren; Monika Àdori; Yu Feng; Ganesh E Phad; Néstor Vázquez Bernat; Shridhar Bale; Jidnyasa Ingale; Viktoriya Dubrovskaya; Sijy O'Dell; Lotta Pramanik; Mats Spångberg; Martin Corcoran; Karin Loré; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

10.  Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia.

Authors:  Dyantha I van der Lee; Rogier M Reijmers; Maria W Honders; Renate S Hagedoorn; Rob Cm de Jong; Michel Gd Kester; Dirk M van der Steen; Arnoud H de Ru; Christiaan Kweekel; Helena M Bijen; Inge Jedema; Hendrik Veelken; Peter A van Veelen; Mirjam Hm Heemskerk; J H Frederik Falkenburg; Marieke Griffioen
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.